22 September 2023
Current Oncology | Top Cited Papers in 2022 in the Section “Cell Therapy”

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2022 top cited papers in the Section “Cell Therapy” below:

1. “A Portrait of SARS-CoV-2 Infection in Patients Undergoing Hematopoietic Cell Transplantation: A Systematic Review of the Literature”
by Adrian J. M. Bailey, Aidan M. Kirkham, Madeline Monaghan, Risa Shorr, C. Arianne Buchan, Christopher Bredeson and David S. Allan
Curr. Oncol. 2022, 29(1), 337-349; https://doi.org/10.3390/curroncol29010030
Available online: https://www.mdpi.com/1718-7729/29/1/30

2. “A Scoping Review on Outcomes and Outcome Measurement Instruments in Rehabilitative Interventions for Patients with Haematological Malignancies Treated with Allogeneic Stem Cell Transplantation”
by Anastasios I. Manettas, Panagiotis Tsaklis, Dario Kohlbrenner and Lidwine B. Mokkink
Curr. Oncol. 2022, 29(7), 4998-5025; https://doi.org/10.3390/curroncol29070397
Available online: https://www.mdpi.com/1718-7729/29/7/397

3. “Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton’s Tyrosine Kinase Inhibitor in Canada”
by Graeme Ball, Christopher Lemieux, David Cameron and Matthew D. Seftel
Curr. Oncol. 2022, 29(3), 2021-2045; https://doi.org/10.3390/curroncol29030164
Available online: https://www.mdpi.com/1718-7729/29/3/164

4. “Abstracts of the Cell Therapy Transplant Canada 2022 Annual Conference”
by Stephanie A. Maier, Tobias Berg, Susan Berrigan, Jonathan Bramson, Chris Bredeson, Guy Cantin, Andrew Daly, Gwynivere A. Davies, Mahmoud Elsawy, Alejandro Garcia-Horton et al.
Curr. Oncol. 2022, 29(12), 9970-10017; https://doi.org/10.3390/curroncol29120783
Available online: https://www.mdpi.com/1718-7729/29/12/783

5. “Access to Hematopoietic Stem Cell Transplant in Canada for Patients with Acute Myeloid”
by Oluwatobiloba Morakinyo, Oliver Bucher and Kristjan Paulson
Curr. Oncol. 2022, 29(8), 5198-5208; https://doi.org/10.3390/curroncol29080412
Available online: https://www.mdpi.com/1718-7729/29/8/412

6. “Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome”
by Yasmine Kadri, Michelle Phan, Nadia Bambace, Léa Bernard, Sandra Cohen, Jean-Sébastien Delisle, Thomas Kiss, Sylvie Lachance, Denis-Claude Roy, Guy Sauvageau et al.
Curr. Oncol. 2022, 29(8), 5955-5962; https://doi.org/10.3390/curroncol29080470
Available online: https://www.mdpi.com/1718-7729/29/8/470

Back to TopTop